BSR
BSR
  • Home
  • Distressed Businesses
    • All Distressed Businessess
    • Administrations
    • Liquidations
    • Winding Up
    • Insolvency Advice  New
  • Buy a Business
    • All Businesses for Sale
    • Find a Business for Sale
    • Raising Business Finance
    • Buyer Acquisition Service   New
    • Escrow Service   New
  • Sell a Business
    • Sell Your Business
    • Seller Accounts
    • Need Help Selling?
    • Help With Finance New
    • Business Valuation
    • Business Wanted Adverts
  • Insights & News
    • View All News
    • View All Insights
  • Off-market
    • Source deals
  • Log In
  • Join Now
Join now
11111111

Home / Insights / Pharmaceutical businesses start M&A trend

Pharmaceutical businesses start M&A trend

SECTOR GUIDES

A recent spate of mergers and acquisitions in the pharmaceuticals industry could be the beginning of a trend towards consolidation amongst Europe's smaller firms.

The sector has seen three deals in five days, beginning on 21st September with the acquisition of the Swiss biotechnology company Serono by Merck of Germany for €10.6bn, and followed the very same day by the sale of fellow German company Altana's drugs division to the unlisted Nycomed of Denmark for €4.5bn. Belgian firm UCB completed the trio four days later the when another German company, Schwartz Pharma, accepted its €4.5bn cash-and-shares offer.

The three deals, of which all the targets were privately-owned, medium-sized specialised pharmaceutical companies, have been influenced by several common factors. Medium-sized pharmaceuticals are increasingly looking to scale up their operations in order to compete with the multinationals who have a steady flow of products in the pipeline, greater distribution networks and more resources for research and development. The German connection is also significant: health reforms in Germany have put added pressure on the domestic market, as government attempts to cut healthcare bills have forced German pharmaceuticals diversify their sales base abroad. Finally, all three acquired companies were family-owned, which can often make the deal process more problematic with many families reluctant to let go of their heritage and reputation.

Nevertheless, analysts have also been careful to point out the differences between the deals and concede that there is likely to be an element of chance in the timing of the transactions. While Altana and Serono both clearly suffered from a shortage of products and were in a weak position having failed to sell at auction, Schwartz Pharma's alliance with UCB is widely accepted as more strategic. Schwartz has a good pipeline of products and its union with UCB will create a company with a turnover of €3.3bn, increasing marketing and distribution capabilities for Schwartz and providing UCB with more late-stage products and increasing its reach in Europe and the States.

Looking to the future, the M&A trend looks likely to continue with further companies tipped to bow to the pressures of consolidation. Danish company Lundbeck is reported to be in talks, and while others such as UK firm Shire Pharmaceuticals stress their ability to remain independent, surviving alone in an increasingly competitive market is becoming more and more difficult.


Share this article



Latest Businesses for Sale

HR Consultancy Practice
UK Wide

An outsourced employment law and HR specialist offering a comprehensive range of services for clients throughout the UK.

Asking Price: Offers Invited
Turnover: £500,000

LEASEHOLD


Provider of Bespoke Art Conservation & Restoration Services
UK Wide

The company offers personalised services to a growing client base, ensuring all art mounting, conservation and restoration requirements are met by a team of highly skilled specialists. Serving museums, galleries, Government departments and private co...

Asking Price: Offers Invited
Turnover: £695,000

LEASEHOLD


Provider of Windows & Doors Solutions
North West, UK

Based in north West England. The business supplies, installs and maintains high-quality window and door systems for its clients. The company has developed a strong reputation due to a proven track record of supporting its customers and local communit...

Asking Price: Offers Invited
Turnover: £1,000,000

FREEHOLD



View more businesses for sale

Search Insights

Latest Insights

Tips for scaling up your six-figure business prior to a sale

FOR BUYERS

2023: An outlook on developing M&A trends

INDUSTRY INSIGHTS

Elon Musk, Twitter and Acquisition Mistakes

INDUSTRY INSIGHTS

Free guide: 10 Biggest Buyer Mistakes

Sign up to receive our acquisition alert emails to get your FREE guide

Email


Insight Categories

  • - For Buyers
  • - For Sellers
  • - Distressed Businesses
  • - Industry Insights
  • - Sector Guides

View all insights

Want access to the latest businesses for sale?

Business Sale Report is your complete solution to finding great acquisition opportunities.

Join today to receive:

  • Comprehensive range of businesses for sale
  • Make direct contact with business sellers or their intermediaries
  • Access to all UK administrations, liquidations and winding-up petitions
  • Daily email alerts for the latest businesses for sale & distressed notifications
  • Business Sale Report publication posted to you every month
  • Advertise your acquisition requirements on our "business wanted" section

All this and much more, including the latest M&A news and exclusive resources

Become a Member
logo
Our Services Distressed Businesses
  • Businesses for Sale
  • Distressed Companies
  • List a Business
  • Help with Finance
  • Buyer Acquisition Service
  • Small Businesses for Sale
Company Buy a Business
  • About BSR
  • Insights
  • News
  • FAQs
  • Reviews
Get In Touch
020 8875 0200
[email protected]
167 Oakhill Road, London, SW15 2QW
Working hours: Mon-Fri, 9am - 5:30pm
About BSR
Business Sale Report is the UK's leading
independent business for sale & distressed business listing service.
Established in 1995, BSR offers an up-to-the-minute, comprehensive overview of businesses for sale, latest distressed business listings and daily acquisition news.
Subscribe

Subscribe to our newsletter to receive news about the latest businesses for sale.

  • Terms
  • Privacy
  • linkedin
  • facebook
  • twitter
© 1995-2023. Business Sale Report Ltd. All rights reserved. www.business-sale.com.